Available Until 10/4/2024

Ordering and Administering COVID-19 Therapeutics: Casirivimab and Imdevimab

ACPE Number: 0204-0000-21-082-H01-P/T
Content Release Date: 10/4/2021
Expiration Date: 10/4/2024
Activity Type: Knowledge-based
CE Credits: 1.25 Contact hours
Activity Fee: Free

Activity Overview

The U.S. Department of Health and Human Services has amended the declaration for medical countermeasures against COVID-19 under the Public Readiness and Emergency Preparedness (PREP) Act to allow qualified pharmacists to order, and qualified pharmacists, pharmacy technicians, and pharmacy interns to administer specific COVID-19 therapeutics. Recent changes to monoclonal antibody emergency-use authorizations (EUAs) allow administration for post-exposure prophylaxis and additional routes of administration. This educational activity will explain the recent PREP Act declaration amendment, including qualifying criteria for pharmacy personnel, and discuss clinical considerations for ordering and administering subcutaneous COVID-19 monoclonal antibodies. This activity will also explain requirements for post-administration observation and emergency reaction recognition and response.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Pharmacists, pharmacy interns, and pharmacy technicians desiring to meet qualifications as defined in the Public Readiness and Emergency Preparedness (PREP) Act declaration to order and/or administer select COVID-19 therapeutics. Pharmacists, pharmacy interns, and pharmacy technicians with an interest in learning more about COVID-19 therapeutics.

  • Discuss COVID-19 monoclonal antibodies (mAbs) currently available and their role in the treatment and/or post-exposure prophylaxis of COVID-19.
  • Describe clinical considerations and contraindications for available COVID-19 mAbs.
  • Give examples of infusion or administration reactions to mAbs and how to respond.

  • Introduction and Announcements
  • Presentation
  • Questions, Answers, and Discussion

  • Michael Ganio, PharmD, MS, BCSCP, FASHP, Senior Director Pharmacy Practice and Quality, ASHP
  • Katherine Yang, PharmD MPH, UCSF Clinical Professor, UCSF San Francisco Medical Center, Infectious Diseases Clinical Pharmacist
  • Sarah Edgerly, PharmD, University of Kentucky, Pediatric Clinical Pharmacist

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.

This activity consists of recordings of faculty slides presentations with embedded self- assessment. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP eLearning Portal. Follow the prompts online to complete the evaluation, claim credit, and view the statement of credit immediately after completing the activity.

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Claim your CE at http://elearning.ashp.org. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.